JP2013544809A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013544809A5 JP2013544809A5 JP2013537197A JP2013537197A JP2013544809A5 JP 2013544809 A5 JP2013544809 A5 JP 2013544809A5 JP 2013537197 A JP2013537197 A JP 2013537197A JP 2013537197 A JP2013537197 A JP 2013537197A JP 2013544809 A5 JP2013544809 A5 JP 2013544809A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- composition according
- over
- period
- peg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 28
- 239000002202 Polyethylene glycol Substances 0.000 claims 11
- 229920001223 polyethylene glycol Polymers 0.000 claims 11
- 206010009944 Colon cancer Diseases 0.000 claims 7
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims 7
- 239000004698 Polyethylene Substances 0.000 claims 6
- 241000282412 Homo Species 0.000 claims 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 3
- 229930195725 Mannitol Natural products 0.000 claims 3
- 239000000594 mannitol Substances 0.000 claims 3
- 235000010355 mannitol Nutrition 0.000 claims 3
- 229960001855 mannitol Drugs 0.000 claims 3
- 239000007787 solid Substances 0.000 claims 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 2
- 239000008101 lactose Substances 0.000 claims 2
- 239000000314 lubricant Substances 0.000 claims 2
- 206010010774 Constipation Diseases 0.000 claims 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims 1
- 208000037062 Polyps Diseases 0.000 claims 1
- 229920002472 Starch Polymers 0.000 claims 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims 1
- 230000002159 abnormal effect Effects 0.000 claims 1
- 239000007894 caplet Substances 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 239000001913 cellulose Substances 0.000 claims 1
- 235000010980 cellulose Nutrition 0.000 claims 1
- 229920002678 cellulose Polymers 0.000 claims 1
- 229940096516 dextrates Drugs 0.000 claims 1
- 239000003792 electrolyte Substances 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 claims 1
- 235000019634 flavors Nutrition 0.000 claims 1
- 235000003599 food sweetener Nutrition 0.000 claims 1
- 230000002496 gastric effect Effects 0.000 claims 1
- 239000008187 granular material Substances 0.000 claims 1
- 230000003862 health status Effects 0.000 claims 1
- 239000004615 ingredient Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000000845 maltitol Substances 0.000 claims 1
- 235000010449 maltitol Nutrition 0.000 claims 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims 1
- 229940035436 maltitol Drugs 0.000 claims 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims 1
- 208000014081 polyp of colon Diseases 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 230000000750 progressive effect Effects 0.000 claims 1
- 239000008247 solid mixture Substances 0.000 claims 1
- 239000000600 sorbitol Substances 0.000 claims 1
- 239000008107 starch Substances 0.000 claims 1
- 235000019698 starch Nutrition 0.000 claims 1
- 239000003765 sweetening agent Substances 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- -1 troche Substances 0.000 claims 1
- 239000000811 xylitol Substances 0.000 claims 1
- 235000010447 xylitol Nutrition 0.000 claims 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims 1
- 229960002675 xylitol Drugs 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1018650.0 | 2010-11-04 | ||
| GBGB1018650.0A GB201018650D0 (en) | 2010-11-04 | 2010-11-04 | Methods and compositions |
| US41212810P | 2010-11-10 | 2010-11-10 | |
| US61/412,128 | 2010-11-10 | ||
| PCT/GB2011/001561 WO2012059725A1 (en) | 2010-11-04 | 2011-11-04 | Peg or peg block copolymers for treating colorectal cancer |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013544809A JP2013544809A (ja) | 2013-12-19 |
| JP2013544809A5 true JP2013544809A5 (enExample) | 2014-11-27 |
| JP5917537B2 JP5917537B2 (ja) | 2016-05-18 |
Family
ID=43414365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013537197A Expired - Fee Related JP5917537B2 (ja) | 2010-11-04 | 2011-11-04 | 結腸直腸ガンを治療するためのｐｅｇ又はｐｅｇブロックコポリマー |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US20130216493A1 (enExample) |
| EP (1) | EP2635289B1 (enExample) |
| JP (1) | JP5917537B2 (enExample) |
| KR (1) | KR20130109171A (enExample) |
| CN (1) | CN103313719A (enExample) |
| AR (1) | AR083770A1 (enExample) |
| AU (1) | AU2011324996B2 (enExample) |
| BE (1) | BE1019494A3 (enExample) |
| BR (1) | BR112013011012A2 (enExample) |
| CA (1) | CA2816839A1 (enExample) |
| EA (1) | EA201300540A1 (enExample) |
| ES (1) | ES2401269B1 (enExample) |
| GB (1) | GB201018650D0 (enExample) |
| MX (1) | MX349690B (enExample) |
| MY (1) | MY163067A (enExample) |
| NL (1) | NL2007715C2 (enExample) |
| NZ (1) | NZ611145A (enExample) |
| SG (1) | SG189533A1 (enExample) |
| TW (1) | TWI606832B (enExample) |
| UA (1) | UA107998C2 (enExample) |
| WO (1) | WO2012059725A1 (enExample) |
| ZA (1) | ZA201304052B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI535461B (zh) | 2011-03-11 | 2016-06-01 | 諾金私人有限公司 | 結腸清潔溶液、用於製備該溶液之組成物、包含該組成物或溶液之套組、與製備該溶液之方法 |
| KR20170098980A (ko) | 2012-09-11 | 2017-08-30 | 노어긴 비.브이. | Peg 및 아스코르베이트를 포함하는 조성물 |
| AR093153A1 (es) * | 2012-10-26 | 2015-05-20 | Northshore Univ Healthsystem | Composiciones que comprenden polietilenglicol para la terapia del carcinoma de celulas escamosas de cabeza y cuello |
| CN103083733A (zh) * | 2013-02-19 | 2013-05-08 | 华熙福瑞达生物医药有限公司 | 一种医用体腔器械导入水性润滑剂 |
| CN113507933B (zh) * | 2019-03-05 | 2024-05-10 | 陶氏环球技术有限责任公司 | 诱导胱天蛋白酶活性 |
| EP3934663B1 (en) * | 2019-03-05 | 2024-06-26 | Dow Global Technologies LLC | Polyethyleneglycol derivatives for use in treating cancer and/or inducing caspase activity |
| US12251399B2 (en) | 2019-03-05 | 2025-03-18 | Dow Global Technologies Llc | Inducing caspase activity |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2784897B1 (fr) | 1998-10-27 | 2002-11-29 | Agronomique Inst Nat Rech | Utilisation d'un laxatif osmotique non fermente dans le traitement et la prevention des cancers colorectaux |
| AU2006244112B2 (en) * | 2005-05-06 | 2011-02-17 | Salix Pharmaceuticals, Inc. | Polyethylene glycol colonic purgative composition |
| US8457025B2 (en) * | 2009-08-28 | 2013-06-04 | Telefonaktiebolaget L M Ericsson (Publ) | Method and network node for selecting a network prefix to be advertised in a communication network |
-
2010
- 2010-11-04 GB GBGB1018650.0A patent/GB201018650D0/en not_active Ceased
-
2011
- 2011-04-11 UA UAA201307040A patent/UA107998C2/uk unknown
- 2011-11-04 EA EA201300540A patent/EA201300540A1/ru unknown
- 2011-11-04 MY MYPI2013001602A patent/MY163067A/en unknown
- 2011-11-04 JP JP2013537197A patent/JP5917537B2/ja not_active Expired - Fee Related
- 2011-11-04 MX MX2013004963A patent/MX349690B/es active IP Right Grant
- 2011-11-04 AR ARP110104129A patent/AR083770A1/es unknown
- 2011-11-04 NL NL2007715A patent/NL2007715C2/en not_active IP Right Cessation
- 2011-11-04 BR BR112013011012A patent/BR112013011012A2/pt not_active IP Right Cessation
- 2011-11-04 SG SG2013032008A patent/SG189533A1/en unknown
- 2011-11-04 US US13/883,262 patent/US20130216493A1/en not_active Abandoned
- 2011-11-04 EP EP11785050.3A patent/EP2635289B1/en active Active
- 2011-11-04 KR KR1020137013977A patent/KR20130109171A/ko not_active Ceased
- 2011-11-04 WO PCT/GB2011/001561 patent/WO2012059725A1/en not_active Ceased
- 2011-11-04 TW TW100140231A patent/TWI606832B/zh not_active IP Right Cessation
- 2011-11-04 ES ES201131772A patent/ES2401269B1/es not_active Expired - Fee Related
- 2011-11-04 NZ NZ611145A patent/NZ611145A/en not_active IP Right Cessation
- 2011-11-04 CN CN201180064013XA patent/CN103313719A/zh active Pending
- 2011-11-04 BE BE2011/0645A patent/BE1019494A3/fr not_active IP Right Cessation
- 2011-11-04 AU AU2011324996A patent/AU2011324996B2/en not_active Ceased
- 2011-11-04 CA CA2816839A patent/CA2816839A1/en not_active Abandoned
-
2013
- 2013-06-03 ZA ZA2013/04052A patent/ZA201304052B/en unknown
-
2016
- 2016-04-21 US US15/134,410 patent/US20160228467A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Ali et al. | Dental erosion caused by silent gastroesophageal reflux disease | |
| Kurin et al. | Sorting out the relationship between gastroesophageal reflux disease and sleep | |
| CY1119886T1 (el) | Μεθοδος βιομηχανικης κατασκευης μιας φαρμακευτικης συνθεσης στην μορφη δισκιων παρατεταμενης απελευθερωσης που περιεχουν πιρφενιδονη και χρηση αυτων στην υποστροφη χρονιας νεφρικης ανεπαρκειας, καψικης συσπασης μαστου και ηπατικης ινωσης σε ανθρωπους | |
| JP2012533565A5 (enExample) | ||
| TW200843802A (en) | Compositions for improving gastrointestinal nutrient and drug absorption | |
| US20180116976A1 (en) | Methods and compositions for unwanted or abnormal muscle contractions | |
| JP2014500246A5 (enExample) | ||
| JP2020055856A (ja) | 経口薬剤用補助手段としての組成物 | |
| EP2635289B1 (en) | Peg or peg block copolymers for treating colorectal cancer | |
| ITMI20092198A1 (it) | Ferro bisglicinato chelato per uso nel trattamento per via orale dell'anemia in pazienti celiaci. | |
| EP3236949B1 (en) | Product based on iron bis-glycinate chelate and alginic acid and/or water-soluble salts thereof, formulations thereof, and pharmaceutical uses thereof | |
| EP2642980B1 (en) | Pediatric formulation | |
| JP6779871B2 (ja) | がん患者のための口腔ケア用組成物 | |
| JP2010106019A (ja) | リマプロストを含有してなる癌化学療法に起因する末梢神経障害予防、治療および／または症状軽減剤 | |
| JP2007169247A (ja) | ショウガ含有経口組成物 | |
| JP2021066751A (ja) | 経口用医薬組成物 | |
| US20210177805A1 (en) | Use of gaboxadol in the treatment of gastrointestinal tract disorders and asthma | |
| JP2018505901A5 (enExample) | ||
| JP2017513866A5 (enExample) | ||
| JP6641626B2 (ja) | 制酸用医薬組成物 | |
| BR112014007022B1 (pt) | composição farmacêutica, método e uso de uma composição farmacêutica | |
| JP2012097034A5 (enExample) | ||
| JP6762007B2 (ja) | 変形性関節症予防用組成物、変形性関節症予防用食品組成物、変形性関節症予防用食品添加物及び変形性関節症予防用医薬 | |
| JP2003095981A (ja) | 医薬組成物 | |
| CN111246753A (zh) | 用于钙补充的组合物 |